ArticleDrug design, development and therapy2019

Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis.

Masashi Sakayori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.